Project measures / variables set:   CSNA03   dist_f30_cocaine_in

ID, description, units MPD:90331   dist_f30_cocaine_in   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]  
cocaine study
Measures
• day:    • 1    • 2    • 3    • 5    • 7    • 9    • 11    • 12    • 19
Data set, strains CSNA03   inbred w/CC8   10 strains     sex: both     age: 8-14wks
Procedure open field test
Comparisontimecourse, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

CSNA03 - distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders


  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
within   day 8 147242158.5245 18405269.8156 2.8994 0.0034
within   day:sex 8 59439558.153 7429944.7691 1.1705 0.3141
within   day:strain 64 893693988.5177 13963968.5706 2.1998 < 0.0001
within   day:sex:strain 64 479685738.5781 7495089.6653 1.1807 0.1643
within   Residuals 800 5078301260.7367 6347876.5759
between   sex 1 352242922.9048 352242922.9048 9.28 0.003
between   strain 8 17300201586.0655 2162525198.2582 56.9725 < 0.0001
between   sex:strain 8 747152083.463 93394010.4329 2.4605 0.0178
between   Residuals 100 3795738064.7209 37957380.6472

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested		SexAge
CSNA03 90331 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 1  dist_f30_cocaine_in_d1 inbred w/CC8 10 both 8-14wks
CSNA03 90337 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 2  dist_f30_cocaine_in_d2 inbred w/CC8 10 both 8-14wks
CSNA03 90343 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 3  dist_f30_cocaine_in_d3 inbred w/CC8 10 both 8-14wks
CSNA03 90349 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 5  dist_f30_cocaine_in_d5 inbred w/CC8 10 both 8-14wks
CSNA03 90355 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 7  dist_f30_cocaine_in_d7 inbred w/CC8 10 both 8-14wks
CSNA03 90361 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 9  dist_f30_cocaine_in_d9 inbred w/CC8 10 both 8-14wks
CSNA03 90367 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 11  dist_f30_cocaine_in_d11 inbred w/CC8 10 both 8-14wks
CSNA03 90373 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 12  dist_f30_cocaine_in_d12 inbred w/CC8 10 both 8-14wks
CSNA03 90379 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders   [cm]   day 19  dist_f30_cocaine_in_d19 inbred w/CC8 10 both 8-14wks



  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder